Neurology
Neuromuscular Block
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Neuromuscular Block is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
33
clinical trials
Completed22 · 67%
Unknown status7 · 21%
Recruiting2 · 6%
Terminated1 · 3%
Withdrawn1 · 3%
Clinical Trials
Trial Activity
33 trials
Remifentanil in Deep vs Moderate Neuromuscular Blocks During Surgical Pleth Index-guided Anesthesia for Laparoscopic Herniorrhaphy
Completed·—·N/A·NCT04022733·134 enrolled
Deep vs Moderate Neuromuscular Blocks on Remifentanil for Laparoscopic Gastrectomy
Completed·—·N/A·NCT04205097·120 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)